BP002857-PRO-852: Recombinant human GNLY Protein
Source: E. coli-derived.
Purity: > 95.0% as determined by SDS-PAGE.APIM050215: OTS-964
CAS No.: 1338545-07-5.
Purity: Refer to Certificate of Analysis, Batch-specific.
QC: HPLC-MS, 1HNMR, Chiral HPLC and Quatitative Elemental Analysis.
Solubility: Soluble in DMSO.C025P: Durvalumab Biosimilar, PD-L1 Monoclonal Antibody
Recombinant Humanized IgG1 Monoclonal Antibody.
Specificity/Sensitivity: The in vivo grade durvalumab biosimilar specifically binds to the human programmed cell death ligand 1 (PD-L1), blocking its interaction with PD-1 and B7-1.
Applications: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by durvalumab.